175
Views
1
CrossRef citations to date
0
Altmetric
Articles

Immunohistochemical and histophysiological study of prolonged use of nandrolone on reproductive organs and fertility

, , , , , , ORCID Icon & ORCID Icon show all

References

  • Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE. 2017. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod. 32:923–936. doi:10.1093/humrep/dex036
  • Acevedo P, Jorge JC, Cruz-Sánchez A, Amy E, Barreto-Estrada JL. 2011. A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico. West Ind Med J. 60:531–535.
  • Andrade GHB, Simão VA, Souza BR, Chuffa LGA, Camargo ICC. 2018. Sex steroid receptors profiling is influenced by nandrolone in the ampulla of the Fallopian tube: post-treatment and post-recovery analyses. Tissue Cell. 50:79–88. doi:10.1016/j.tice.2018.01.001
  • Behner OA, Tolosa ENP, Freitas Neto AG. 1976. Manual de técnicas para histologia normal e patológica. Ed. EDART, São Paulo, Brazil.
  • Belardin LB, Simão VA, Leite GAA, Chuffa LGA, Camargo ICC. 2014. Dose dependent effects and reversibility of the injuries caused by nandrolone in uterine tissue and fertility of rats. Birth Def Res B Dev Reprod Toxicol. 101:168–177. doi:10.1002/bdrb.21104
  • Boff SR. 2010. Esteroides anabólicos e exercício: ação e efeitos colaterais. Rev Bras Cienc Mov. 18:81–88. doi:10.1590/S1517-86922010000300007
  • Bokal EV, Vrtovec HM, Klun IV, Verdenik I. 2005. Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome. Hum Reprod. 20:1562–1568. doi:10.1093/humrep/deh789
  • Bokal EV, Klun IV, Verdenik I. 2009. Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Reprod Biomed Online. 18:21–28. doi:10.1016/s1472-6483(10)60420-8
  • Bonetti A, Tirelli F, Catapano A, Dazzi D, Dei Cas A, Solito F, Ceda G, Reverberi C, Monica C, Pipitone S, Elia G, Spattini M, Magnati G. 2008. Side effects of anabolic androgenic steroids abuse. Int J Sports Med. 29:679–687. doi:10.1055/s-2007-965808
  • Borish LC, Steinke JW. 2003. Cytokines and chemokines. J Aller Clin Immunol. 11:460–475. doi:10.1067/mai.2003.108
  • Brenner RM, Nayak NR, Slayden OD, Critchley HO, Kelly RW. 2002. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann NY Acad Sci. 955:60–74. doi:10.1111/j.1749-6632.2002.tb02766.x
  • Breuer ME, Mcginnis MY, Lumia AR, Possidente BP. 2001. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Horm Behav. 40:409–418. doi:10.1006/hbeh.2001.1706
  • Bromer JG, Aldad TS, Taylor HS. 2009. Defining the proliferative phase endometrial defect. Fertil Steril. 91:698–704. doi:10.1016/j.fertnstert.2007.12.066
  • Caliman IF, Bernabe CS Jr, de Melo AF, Brasil GA, Do Nascimento AM, de Lima EM, Figueiredo SG, de Andrade TU, Bissoli NS. 2017. Long-term treatment with nandrolone impairs mesenteric vascular relaxation in both sedentary and exercised female rats. Steroids. 120:7–18. doi:10.1016/j.steroids.2017.02.001
  • Camargo ICC, Barreiros de Souza R, de Fátima PMS, Chuffa LGA, Frei F. 2009. Ovarian histology and follicular score in female rats treated with nandrolone and submitted to physical effort. Acta Biol Hung. 60:253–261. doi:10.1556/ABiol.60.2009.3.2
  • Camargo ICC, Leite GAA, Pinto T, Paes JTR. 2014. Histopathological findings in the ovaries and uterus of albino female rats promoted by co-administration of synthetic steroids and nicotine. Exp Toxicol Pathol. 66:195–202. doi:10.1016/j.etp.2014.01.005
  • Caraci F, Pistara V, Corsaro A, Tomasello F, Giuffrida ML, Sortino MA, Nicoletti F, Copani A. 2011. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. J Neurosci Res. 89:592–600. doi:10.1002/jnr.22578
  • Cunningham RL, Giuffrida A, Roberts JL. 2009. Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase C delta. Endocrinology. 150:5539–5548. doi:10.1210/en.2009-0640
  • Davani-Davari D, Karimzadeh I, Khalili H. 2019. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrol. 20:198–209. doi:10.1186/s12882-019-1384-0
  • Demir B, Guven S, Guven ES, Atamer Y, Gul T. 2009. Serum IL-6 level may have role in the pathophysiology of unexplained infertility. Am J Reprod Immunol. 62:261–267. doi:10.1111/j.1600-0897.2009.00734.x
  • Fluttert M, Dalm S, Oitz MS. 2000. A refined method for sequential blood sampling by tail incision in rats. Lab Anim. 34:372–378. doi:10.1258/002367700780387714
  • Frizon F, Macedo SMD, Yonamine M. 2009. Uso de esteróides andrógenos nabólicos por praticantes de atividade física das principais academias de Erechim e Passo Fundo/RS. Rev Bras Cienc Farm. 26:227–232.
  • Gerez JR, Frei F, Camargo IC. 2005. Histological assessment of ovaries and uterus of rats subjected to nandrolone treatment. Contraception. 72:77–80. doi:10.1016/j.contraception.2005.02.001
  • Geva E, Jaffe RB. 2000. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril. 74:429–438. doi:10.1016/s0015-0282(00)00670-1
  • Gosden RG, Laing SC, Felicio LS, Nelson JF, Finch CE. 1983. Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice. Biol Reprod. 28:255–260. doi:10.1095/biolreprod28.2.255
  • Gougeon A, Chainy GB. 1987. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil. 81:433–442. doi:10.1530/jrf.0.0810433
  • Hartgens F, Kuipers H. 2004. Effects of androgenic-anabolic steroids in athletes. Sports Med. 34:513–554. doi:10.2165/00007256-200434080-00003
  • Hoffman JR, Ratamess NA. 2006. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 5:182–193.
  • Huang TS, Chen YJ, Chou TY, Chen CY, Li HY, Huang BS, Tsai HW, Lan HY, Chang CH, Twu NF, Yen MS, Wang PH, Chao KC, Lee CC, Yang MH. 2014. Oestrogen-induced angiogenesis promotes adenomyosis by activating the slug-VEGF axis in endometrial epithelial cells. J Cell Mol Med. 18:1358–1371. doi:10.1111/jcmm.12300
  • Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ. 1995. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol. 17:857–863. doi:10.1016/0192-0561(95)00078-x
  • Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. 2010. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 20:475–481. doi:10.1097/JSM.0b013e3181fb5370
  • Iriart JAB, Chaves JC, Orleans RG. 2009. Culto ao corpo e uso de anabolizantes entre praticantes de musculação. Cad Saude Publ. 25:773–782. doi:10.1590/S0102-311X2009000400008
  • Irving LM, Wall M, Neumark-Sztainer D, Story M. 2002. Steroid use among adolescents: findings from Project EAT. J Adolesc Health. 30:243–252. doi:10.1016/s1054-139x(01)00414-1
  • Junqueira LCU, Junqueira LMMS. 1983. Técnicas básicas de citologia e histologia. Guanabara Koogan, São Paulo, Brazil.
  • Kaczmarek M, Schams D, Ziecik AJ. 2005. Role of vascular endothelial growth factor in ovarian physiology–an overview. Reprod Biol. 2:111–136. doi:10.1016/s0015-0282(00)00670-1
  • Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H. 2010. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 25:642–653. doi:10.1093/humrep/dep437
  • Kicman AT. 2008. Pharmacology of anabolic steroids. Br J Pharmacol. 104:502–521. doi:10.1038/bjp.2008.165
  • Kohler RMN, Lambert MI. 2002. Urine nandrolone metabolites: false positive doping test? J Sports Sci Med. 36:325–329. doi:10.1136/bjsm.36.5.325
  • Kurachi O, Matsuo H, Samoto T, Maruo T. 2001. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab. 86:2275–2280. doi:10.1210/jcem.86.5.7469
  • Lee ES, Kim JH, Im S, Lee KB, Sohn S, Kang WH. 2001. Application of computerized image analysis in pigmentary skin diseases. Int J Dermatol. 40:45–49. doi:10.1046/j.1365-4362.2001.00084.x
  • Liu H, Liu K, Bodenner DL. 2005. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation. Cytokine. 31:251–257. doi:10.1016/j.cyto.2004.12.008
  • Lucci CM, Amorim CA, Rodrigues APR, Figueiredo JR, Báo SN, Silva JRV, Gonçalves PBD. 1999. Study of preantral follicle population in situ and after mechanical isolation from caprine ovaries at different reproductive stages. Anim Reprod Sci. 56:223–236. doi:10.1016/s0378-4320(99)00045-7
  • Malik S, Day K, Perrault I, Charnock-Jones DS, Smith SK. 2006. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-a in menstrual endometrium and effluent in women with menorrhagia. Hum Reprod. 21:2158–2166. doi:10.1093/humrep/del089
  • Mandl AM. 1951. The phases of the oestrous cycle in the adult white rat. J Exp Biol. 28:576–584.
  • Manneras L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. 2007. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 148:3781–3791. doi:10.1210/en.2007-0168
  • Masiukiewicz US, Mitnick M, Grey AB, Insogna KL. 2000. Estrogen modulates parathyroid hormone induced interleukin-6 production in vivo and in vitro. Endocrinology. 141:2526–2531. doi:10.1210/endo.141.7.7537
  • Miller AE, Riegle GD. 1980. Temporal changes in serum progesterone in aging female rats. Endocrinology. 106:1579–1583. doi:10.1210/endo-106-5-1579
  • Mobini Far HR, Agren G, Lindqvist AS, Marmendal M, Fahlke C, Thiblin I. 2007. Administration of the anabolic androgenic steroid nandrolone to female rats causes alterations in the morphology of their uterus and a reduction in reproductive capacity. Eur J Obst Gyn Reprod Biol. 131:189–197. doi:10.1016/j.ejogrb.2006.07.037
  • Moldoveanu AI, Shephard RJ, Shek PN. 2001. The cytokine response to physical activity and training. Sports Med. 31:115–144. doi:10.2165/00007256-200131020-00004
  • Moraes DR, Castiel LD, Ribeiro APPG. 2015. “Não” para jovens bombados,” sim” para velhos empinados: o discurso sobre anabolizantes e saúde em artigos da área biomédica. Cad Saude Publ. 31:1131–1140. doi:10.1590/0102-311X00068914
  • Nelson JF, Felicio LS, Osterburg HH, Finch CE. 1981. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57bl/6J mice. Biol Reprod. 24:784–794. doi:10.1095/biolreprod24.4.784
  • NIDA-National Institute on Drug Abuse. 2006. Number 06-3721. https://www.drugabuse.gov/sites/default/files/rrsteroids_0.pdf.
  • Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BW, Johnson N, Hull ML. 2016. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 5:CD012179. doi:10.1002/14651858.CD012179
  • Noroozzadeh M, Behboudi-Gandevani S, Zadeh-Vakili A, Ramezani Tehrani F. 2017. Hormone-induced rat model of polycystic ovary syndrome: a systematic review. Life Sci. 191:259–272. doi:10.1016/j.lfs.2017.10.020
  • Oberholzer M, Ostreicher M, Christen H, Bruhlmann M. 1996. Methods in quantitative image analysis. Histochem Cell Biol. 105:333–355. doi:10.1007/BF01463655
  • Orlando R, Caruso A, Molinaro G, Motolese M, Matrisciano F, Togna G, Melchiorri D, Nicoletti F, Bruno V. 2007. Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures. Brain Res. 1165:21–29. doi:10.1016/j.brainres.2007.06.047
  • Paixao L, Ramos RB, Lavarda A, Morsh DM, Spritzer PM. 2017. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 15:1–12. doi:10.1186/s12958-017-0231-z
  • Paschoal M, de Cássia Marqueti R, Perez S, Selistre-de-Araujo HS. 2009. Nandrolone inhibits VEGF mRNA in rat muscle. Int J Sports Med. 30:775–778. doi:10.1055/s-0029-1234058
  • Protic O, Toti P, Islam MS, Occhini R, Giannubilo SR, Catherino WH, Cinti S, Petraglia F, Ciavattini A, Castellucci M, Hinz B, Ciarmela P. 2016. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids. Cell Tissue Res. 364:415–427. doi:10.1007/s00441-015-2324-3
  • Qiao J, Feng HL. 2011. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 17:17–33. doi:10.1093/humupd/dmq032
  • Richter KS, Bugge KR, Bromer JG, Levy MJ. 2007. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst stage embryos. Fertil Steril. 87:53–59. doi:10.1016/j.fertnstert.2006.05.064
  • Saddick SY. 2018. The impact of nandrolone administration on ovarian and uterine tissues in rat: luteinizing hormone profile, histopathological and morphometric assessment. Saudi J Biol Sci. 25:507–512. doi:10.1016/j.sjbs.2017.08.015
  • Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, Crampton SP, Davis J, Conn E, Hughes CC. 2008. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood. 111:4997–5007. doi:10.1182/blood-2007-08-108597
  • Shokri S, Aitken RJ, Abdolvahhabi M, Abolhasani F, Ghasemi FM, Kashani I, Ejtemaeimehr S, Ahmadian S, Minaei B, Naraghi MA, Barbarestani M. 2009. Exercise and supraphysiological dose of nandrolone deconoate increase apoptosis in spermatogenic cells. Basic Clin Pharmacol Toxicol. 106:324–330. doi:10.1111/j.1742-7843.2009.00495.x
  • Shokri S, Aitken RJ, Abdolvahhabi M, Abolhasani F, Ghasemi FM, Kashani I. 2010. Exercise and supraphysiological dose of nandrolone deconoate increase apoptosis in spermatogenic cells. Basic Clin Pharmacol Toxicol. 106:324–330. doi:10.1111/j.1742-7843.2009.00495.x
  • Sierra-Mondragón E, Gómez-Chávez F, Murrieta-Coxca M, Vázquez-Sánchez EA, Martínez-Torres I, Cancino-Díaz ME, Rojas-Espinosa O, Cancino-Díaz JC, Reyes-Sánchez JL, Rodríguez-Muñóz R, Rodríguez-Martínez S. 2015. Low expression of IL-6 and TNF-α correlates with the presence of the nuclear regulators of NF-κB, IκBNS and BCL-3, in the uterus of mice. Mol Immunol. 68:333–340. doi:10.1016/j.molimm.2015.09.020
  • Silva EHA, Sales IRP, Oliveira LN, Nascimento JES. 2017. Uterine morphological changes induced by androgenic anabolic steroids. Hum Reprod Arch. 32:e001417. doi:10.4322/hra.001417
  • Simão VA, Chuffa LGA, Camargo ICC. 2016. Ovarian sex steroid receptors and sex hormones in androgenized rats. Reproduction. 152:545–559. doi:10.1530/REP-16-0233
  • Singh KB. 2005. Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril. 84:1228–1234. doi:10.1016/j.fertnstert.2005.06.013
  • Smith JA, Das A, Butler JT, Ray SK, Banik NL. 2011. Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem Res. 36:1587–1593. doi:10.1007/s11064-010-0336-7
  • Teixeira AAC, Simoes MJ, Wanderley-Teixeira V, Soares JM. 2004. Evaluation of the implantation in pinealectomized and/or submitted to the constant illumination rats. Int J Morphol. 22:189–194. doi:10.4067/S0717-95022004000300003
  • Thorlindsson T, Halldorsson V. 2010. Sport, and use of anabolic androgenic steroids among Icelandic high school students: a critical test of three perspectives. Subst Abuse Treat Prev Pol. 5:1–11. doi:10.1186/1747-597X-5-32
  • Wagner PD. 2011. The critical role of VEGF in skeletal muscle angiogenesis and blood flow. Biochem Soc Trans. 39:1556–1559. doi:10.1042/bst20110646
  • Wu X, Cheng B, Cai ZD, Lou LM. 2013. Determination of the apoptotic index in osteosarcoma tissue and its relationship with patients’ prognosis. Cancer Cell Int. 13:1–4. doi:10.1186/1475-2867-13-56
  • Xu X, Du C, Zheng Q, Peng L, Sun Y. 2014. Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. BMC Womens Health. 14:1–7. doi:10.1186/1472-6874-14-93
  • Zanarotti LB. 2012. Avaliação do efeito do esteróide anabólico decanoato denandrolona na morfologia do ovário de ratas adultas. Rev Bras Mult. 20:84–91. doi:10.25061/2527-2675/ReBraM/2017.v20i1.479
  • Zeleznik AJ, Little-Ihrig L, Ramasawamy S. 2004. Administration of dihydrotestosterone to rhesus monkeys inhibits gonadotropin-stimulated ovarian steroidogenesis. J Clin End Metab. 89:860–866. doi:10.1210/jc.2003-031292

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.